BI Asset Management Fondsmaeglerselskab’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,186	Closed	-$100K	–	722
2023 Q4	$100K	Buy	+3,186	New	+$100K	﹤0.01%	682
2020 Q1	–	Sell	-13,829	Closed	-$592K	–	316
2019 Q4	$592K	Buy	+13,829	New	+$592K	0.03%	254